Editor's Picks Analysis & Opinion

Established market wisdom suggests small cap companies tend to outperform large ones over the long-run.However, the past decade has mostly seen small-caps lag large-caps, especially in the US. For...

Vaccine optimism wanes Rising coronavirus cases and fears of additional lockdowns in US states dampen positive sentiment Bitcoin reaches 3-year high Key EventsUS futures, including for the Dow,...

Technology stocks have fallen out of favor in recent sessions, with investors piling into value names, which are typically companies that are more sensitive to economic cycles, in the wake of positive...

The outlook for oil and gasoline has steadily improved over the past three weeks on COVID-19 vaccine hopes, leaving open the question of what may become of ethanol, the biofuel mandated as an additive...

Recent positive news about a COVID-19 vaccine has put the limelight on health-care and pharmaceutical companies, especially BioNTtech (NASDAQ:BNTX), Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE). Today,...

Reports Q3 2021 results on Wednesday, Nov. 18, after the close Revenue expectation: $4.41 billion EPS expectation: $2.57 NVIDIA Corp. (NASDAQ:NVDA) has emerged as the best-performing chip stock...

Tesla to join S&P 500 Index, gaining blue chip status Lockdowns overshadow progress on second vaccine Key EventsThe much-lauded, cyclical rotation out of the technology sector appears to have...

Shares of Canopy Growth (NYSE:CGC), (TSX:WEED) closed yesterday slightly above the height they reached last week when the largest cannabis company on the globe announced its latest quarterly...